123 related articles for article (PubMed ID: 15107186)
1. Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain.
Oliva JM; Ortiz S; Palomo T; Manzanares J
J Psychopharmacol; 2004 Mar; 18(1):59-65. PubMed ID: 15107186
[TBL] [Abstract][Full Text] [Related]
2. Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice.
Aracil-Fernández A; Almela P; Manzanares J
Addict Biol; 2013 Mar; 18(2):252-62. PubMed ID: 22017514
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
4. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
5. Differences in basal cannabinoid CB1 receptor function in selective brain areas and vulnerability to voluntary alcohol consumption in Fawn Hooded and Wistar rats.
Ortiz S; Oliva JM; Pérez-Rial S; Palomo T; Manzanares J
Alcohol Alcohol; 2004; 39(4):297-302. PubMed ID: 15208160
[TBL] [Abstract][Full Text] [Related]
6. Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain.
Oliva JM; Ortiz S; Pérez-Rial S; Manzanares J
Eur Neuropsychopharmacol; 2008 May; 18(5):373-82. PubMed ID: 17964122
[TBL] [Abstract][Full Text] [Related]
7. Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice.
Oliva JM; Ortiz S; Palomo T; Manzanares J
J Neurochem; 2003 Apr; 85(1):94-104. PubMed ID: 12641731
[TBL] [Abstract][Full Text] [Related]
8. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
Chiang YC; Chen JC
J Neurochem; 2007 Dec; 103(6):2505-17. PubMed ID: 17953657
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal.
Navarrete F; Aracil-Fernández A; Manzanares J
Br J Pharmacol; 2018 Jul; 175(13):2676-2688. PubMed ID: 29624642
[TBL] [Abstract][Full Text] [Related]
10. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
11. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.
Cannich A; Wotjak CT; Kamprath K; Hermann H; Lutz B; Marsicano G
Learn Mem; 2004; 11(5):625-32. PubMed ID: 15466318
[TBL] [Abstract][Full Text] [Related]
12. Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice.
Urigüen L; Berrendero F; Ledent C; Maldonado R; Manzanares J
Eur J Neurosci; 2005 Oct; 22(8):2106-10. PubMed ID: 16262648
[TBL] [Abstract][Full Text] [Related]
13. CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis.
Dubreucq S; Koehl M; Abrous DN; Marsicano G; Chaouloff F
Exp Neurol; 2010 Jul; 224(1):106-13. PubMed ID: 20138171
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
15. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting increase in [³H]CP55,940 binding to CB1 receptors following cocaine self-administration and its withdrawal in rats.
Adamczyk P; Faron-Górecka A; Kuśmider M; Dziedzicka-Wasylewska M; Papp M; Filip M
Brain Res; 2012 Apr; 1451():34-43. PubMed ID: 22425184
[TBL] [Abstract][Full Text] [Related]
17. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.
Haller J; Varga B; Ledent C; Barna I; Freund TF
Eur J Neurosci; 2004 Apr; 19(7):1906-12. PubMed ID: 15078564
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain.
Cristino L; de Petrocellis L; Pryce G; Baker D; Guglielmotti V; Di Marzo V
Neuroscience; 2006; 139(4):1405-15. PubMed ID: 16603318
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
González S; Cebeira M; Fernández-Ruiz J
Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
[TBL] [Abstract][Full Text] [Related]
20. Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.
Pérez-Rial S; García-Gutiérrez MS; Molina JA; Pérez-Nievas BG; Ledent C; Leiva C; Leza JC; Manzanares J
Neurobiol Aging; 2011 Apr; 32(4):631-45. PubMed ID: 19419794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
